APO RESEARCH · REPORT
Meglumine
Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-132ºC and the boiling point is 490.4ºC at 760 mmHg.
Product & engineering
Understand the product.
Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-132ºC and the boiling point is 490.4ºC at 760 mmHg.
Meglumine is an amino sugar derived from glucose.
Selected research
Market Outlook & Growth Opportunities
Global Meglumine Market Outlook and Growth Opportunities 2026
Market perspective
Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-132ºC and the boiling point is 490.4ºC at 760 mmHg.
Meglumine is an amino sugar derived from glucose.
Global Meglumine key players include Merck, Tianma, etc. Global top two manufacturers hold a share about 95%.
Read the full market overview
Europe is the largest market, with a share over 70%, followed by India and North America, both have a share about 15 percent.
In terms of application, the largest application is Contrast agent, followed by Cosolvent, etc.
This report provides an overview of the global Meglumine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Meglumine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Meglumine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Meglumine market size, projected growth trends, production technologies, key applications, and end-use industries.
Meglumine Segment by Company
Merck
Tianma
Libang Healthcare Group
New Hualian Pharm
Meglumine Segment by Type
Diatrizoate Meglumine
Lothalamate Meglumine
Lodipamide Meglumine
Meglumine Segment by Application
Cosolvent
Contrast agent
Other
Meglumine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Meglumine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Meglumine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Meglumine significant trends, drivers, influence factors in global and regions.
6. To analyze Meglumine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meglumine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Meglumine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meglumine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Meglumine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Meglumine industry.
Chapter 3: Detailed analysis of Meglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Meglumine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Meglumine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Diatrizoate Meglumine
- Lothalamate Meglumine
- Lodipamide Meglumine
Applications
- Cosolvent
- Contrast agent
- Other
Companies covered
- Merck
- Tianma
- Libang Healthcare Group
- New Hualian Pharm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Meglumine Sales Value (2021-2032)
- 1.2.2 Global Meglumine Sales Volume (2021-2032)
- 1.2.3 Global Meglumine Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Meglumine Market Dynamics
- 2.1 Meglumine Industry Trends
- 2.2 Meglumine Industry Drivers
- 2.3 Meglumine Industry Opportunities and Challenges
- 2.4 Meglumine Industry Restraints
3 Meglumine Market by Company
- 3.1 Global Meglumine Company Revenue Ranking in 2025
- 3.2 Global Meglumine Revenue by Company (2021-2026)
- 3.3 Global Meglumine Sales Volume by Company (2021-2026)
- 3.4 Global Meglumine Average Price by Company (2021-2026)
- 3.5 Global Meglumine Company Ranking (2024-2026)
- 3.6 Global Meglumine Company Manufacturing Base and Headquarters
- 3.7 Global Meglumine Company Product Type and Application
- 3.8 Global Meglumine Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Meglumine Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Meglumine Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Meglumine Market by Type
- 4.1 Meglumine Type Introduction
- 4.1.1 Diatrizoate Meglumine
- 4.1.2 Lothalamate Meglumine
- 4.1.3 Lodipamide Meglumine
- 4.2 Global Meglumine Sales Volume by Type
- 4.2.1 Global Meglumine Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Meglumine Sales Volume by Type (2021-2032)
- 4.2.3 Global Meglumine Sales Volume Share by Type (2021-2032)
- 4.3 Global Meglumine Sales Value by Type
- 4.3.1 Global Meglumine Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Meglumine Sales Value by Type (2021-2032)
- 4.3.3 Global Meglumine Sales Value Share by Type (2021-2032)
5 Meglumine Market by Application
- 5.1 Meglumine Application Introduction
- 5.1.1 Cosolvent
- 5.1.2 Contrast agent
- 5.1.3 Other
- 5.2 Global Meglumine Sales Volume by Application
- 5.2.1 Global Meglumine Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Meglumine Sales Volume by Application (2021-2032)
- 5.2.3 Global Meglumine Sales Volume Share by Application (2021-2032)
- 5.3 Global Meglumine Sales Value by Application
- 5.3.1 Global Meglumine Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Meglumine Sales Value by Application (2021-2032)
- 5.3.3 Global Meglumine Sales Value Share by Application (2021-2032)
6 Meglumine Regional Sales and Value Analysis
- 6.1 Global Meglumine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Meglumine Sales by Region (2021-2032)
- 6.2.1 Global Meglumine Sales by Region: 2021-2026
- 6.2.2 Global Meglumine Sales by Region (2027-2032)
- 6.3 Global Meglumine Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Meglumine Sales Value by Region (2021-2032)
- 6.4.1 Global Meglumine Sales Value by Region: 2021-2026
- 6.4.2 Global Meglumine Sales Value by Region (2027-2032)
- 6.5 Global Meglumine Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Meglumine Sales Value (2021-2032)
- 6.6.2 North America Meglumine Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Meglumine Sales Value (2021-2032)
- 6.7.2 Europe Meglumine Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Meglumine Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Meglumine Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Meglumine Sales Value (2021-2032)
- 6.9.2 South America Meglumine Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Meglumine Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Meglumine Sales Value Share by Country, 2025 VS 2032
7 Meglumine Country-level Sales and Value Analysis
- 7.1 Global Meglumine Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Meglumine Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Meglumine Sales by Country (2021-2032)
- 7.3.1 Global Meglumine Sales by Country (2021-2026)
- 7.3.2 Global Meglumine Sales by Country (2027-2032)
- 7.4 Global Meglumine Sales Value by Country (2021-2032)
- 7.4.1 Global Meglumine Sales Value by Country (2021-2026)
- 7.4.2 Global Meglumine Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Meglumine Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Meglumine Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Meglumine Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Meglumine Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Meglumine Sales Value Growth Rate (2021-2032)
- 7.9.2 France Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Meglumine Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Meglumine Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Meglumine Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Meglumine Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Meglumine Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Meglumine Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Meglumine Sales Value Growth Rate (2021-2032)
- 7.16.2 China Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Meglumine Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Meglumine Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Meglumine Sales Value Growth Rate (2021-2032)
- 7.19.2 India Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Meglumine Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Meglumine Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Meglumine Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Meglumine Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Meglumine Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Meglumine Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Meglumine Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Meglumine Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Meglumine Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Meglumine Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Meglumine Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Meglumine Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Meglumine Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Meglumine Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Meglumine Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Meglumine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Company Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck Meglumine Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Merck Meglumine Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Tianma
- 8.2.1 Tianma Company Information
- 8.2.2 Tianma Business Overview
- 8.2.3 Tianma Meglumine Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Tianma Meglumine Product Portfolio
- 8.2.5 Tianma Recent Developments
- 8.3 Libang Healthcare Group
- 8.3.1 Libang Healthcare Group Company Information
- 8.3.2 Libang Healthcare Group Business Overview
- 8.3.3 Libang Healthcare Group Meglumine Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Libang Healthcare Group Meglumine Product Portfolio
- 8.3.5 Libang Healthcare Group Recent Developments
- 8.4 New Hualian Pharm
- 8.4.1 New Hualian Pharm Company Information
- 8.4.2 New Hualian Pharm Business Overview
- 8.4.3 New Hualian Pharm Meglumine Sales, Value and Gross Margin (2021-2026)
- 8.4.4 New Hualian Pharm Meglumine Product Portfolio
- 8.4.5 New Hualian Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Meglumine Value Chain Analysis
- 9.1.1 Meglumine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Meglumine Sales Mode & Process
- 9.2 Meglumine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Meglumine Distributors
- 9.2.3 Meglumine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst